NEWS
Return
to the home page http://www.imor.org
Retutn
to the english home page http://www.imor.org/index_ang.htm
Consult
the news in English contenido3_ang.htm
Consultar la web en español http://www.imor.org
Consultar las noticias en
español contenido3_cast.htm
Consultar la web en català http://www.imor.org/index_cat.htm
Tornar a la pagina principal de
noticies en català contenido3_cat.htm
Return
to the home page ../index.htm
·
The IMOR
Foundation, Medical Institute for Radiotherapy and Oncology from Barcelona, presents a revolutionary treatment for age related wet
macular degeneration (AMD). The
event was hosted by Professors Dr. Borja
Corcóstegui, Director of the Ocular Microsurgery Institute (IMO) in
Barcelona and Dr Benjamin Guix Melcior, Director of the IMOR Foundation,
Medical Institute for Radiotherapy and Oncology of Barcelona, Spain, who
are serving as a principle investigator for the NeoVista sponsored CABERNET
clinical study. Also on the program were John N. Hendrick, President and CEO of
NeoVista; Dr. Eugene de Juan, vice chairman of ForSight Labs and co-inventor of
the NeoVista technology Brachytherapy in conjunction with the administration of
lucentis is the best treatment for AMD.
·
AMD is one of the most serious conditions
that affect the macula (the part of the eye responsible for central vision) and
is the main cause of irreparable blindness in people over 60. If left untreated,
the condition gives rise to a rapid loss of central best vision.
There are currently more than 164,000 people with wet AMD in Spain, and 30,000
new cases are detected every year. These figures are expected to increase in
the coming years as the population ages. NeoVista has begun a definitive
clinical trial called CABERNET (CNV
Secondary to AMD Treated with BEta RadiatioN Epiretinal Therapy) to demonstrate
the effectiveness of the NeoVista treatment protocol compared to the results
obtained with anti-VEGF therapy alone. This study will recruit 495 patients in
40 clinical sites throughout the world, including the Ocular Microsurgery
Institute (IMO) in Barcelona, which will begin its initial treatments in
February 2008. The IMOR Foundation and the IMO from Barcelona will be the only
Spanish centres treating patients in this extremely important trial. Dr Borja Corcostegui and Dr Benjamin Guix
Melcior will serve as principle investigators and responsible of the
project.
·
To learn more
about prostate cancer treatment by IGRT,
IMRT and Brachytherapy as best
treatment for cancer listen to some of the interview done to Dr Benjamin Guix Melcior, from the IMOR Foundation, Medical Institute for
Radiotherapy and Oncology of Barcelona, Spain, the best treatment for cancer abroad, cut and paste over the link:
http://profesional.medicinatv.com/webcast/muestra.asp?idfg=0&idwc=1387
·
The Combined treatment
Image-guided Intensity Modulated Radiotherapy (IG-IMRT) plus Prostate
Brachytherapy has been demonstrated to be the best approach for intermediate
and high risk prostate cancer,
as presented today at the World Congress of genito urinary cancer held at San
Francisco. The research has been carried-out at The IMOR Foundation, Medical Institute for Radiotherapy and Oncology,
from Barcelona, Spain, one of the
top place to have the best radiotherapy
and brachytherapy abroad, and has been presented by Professor Dr. Benjamin
Guix, MD PhD MBA.
·
The IMOR
Foundation, Medical Institute for Radiotherapy and Oncology, has been
invited to participate in the 13th Puerto Rico Breast Cancer Conference, to expose the recent
developments in the treatment of breast cancer and the future perspectives that
are now opened. Professor Dr Benjamin
Guix MD PhD MBA, Director of The IMOR Foundation, Medical Institute for
Radiotherapy and Oncology, from Barcelona, Spain, will present the
experience of The IMOR Foundation, Medical
Institute for Radiotherapy and Oncology, in partial breast irradiation,
salvage treatment and breast brachytherapy. The IMOR Foundation, Medical Institute for Radiotherapy and Oncology, has
one the best and longest series of patients treated with these advanced
treatments. The IMOR Foundation is considered one of the best place to have cancer treatment abroad and has been
awarded twice with the Best ESTRO
(European Society for Radiotherapy and Oncology) Award, in 2000 and 2007.
At the waterfront of the best treatment
for breast cancer.
·
The European
Society for Radiotherapy and Oncology (ESTRO) has awarded The IMOR Foundation,
Medical Institute for Radiotherapy and Oncology at Barcelona (Spain) with the
BEST BRACHYTHERAPY AWARD. The price was given to The IMOR Foundation for their
contribution to the development of conservative treatment for cancer, mainly prostate cancer. The treatment with brachytherapy, alone or in
combination with external beam radiotherapy, has been demonstrated to produce
the highest rates of cure, while
preserving the Quality of Life at the
best. The award was offered to Professor
Dr Benjamin Guix, MD PhD MBA, Director of The IMOR Foundation, Medical Institute for Radiotherapy and Oncology,
by the president of GEC-ESTRO, Erik Van
Limbergen, at a Gala Dinner held at Montpellier, during the Celebration of
the Annual ESTRO meeting. The IMOR Foundation, Medical Institute for Radiotherapy
and Oncology of Barcelona, Spain, is
considered one on the best place to have the treatment of cancer abroad.
·
IMRT-Brachytherapy
Combined treatment offers the best
long-term results in the treatment for intermediate- and high-risk prostate
cancer. The 16-year free-from-relapse survival rate was higher than 90%.
The results has been published in the International Journal of Radiation
Oncology Biology and employed the same protocol used at The IMOR Foundation, Medical Institute for Radiotherapy and Oncology from Barcelona, Sapin, since 1.999, said
Professor Dr Benjamin Guix. Results are
really spectacular with a survival rate unreached with any other technique,
even with surgery. PROSTATe_TRAT COMB_ENG.htm
·
The IMOR
Foundation, Medical Institute for Radiotherapy and Oncology, from Barcelona
(Spain), starts treating patients with Image
Guided (IGRT) Intensity Modulated Radiotherapy (IMRT) IG-IMRT. This is the
first centre employing this technology of southern Europe. The IG-IMRT program
is directed by Professor Dr Benjamin Guix with the collaboration of Dr Antonio
Arellano, Antonio Martinez, Ferran Guedea, Josep Sole and Manel Algara. IGRT-IMRT is nowadays the best treatment
for cancer, and IMOR Foundation, Medical Institute for Radiotherapy
and Oncology of Barcelona, Spain, is
considered to be the best place to
have cancer treatment abroad. JORNADA_IGRT_IMOR_2006_eng.htm
·
The IMOR
Foundation, Medical Institute for Radiotherapy and Oncology, from Barcelona
(Spain), starts treating patients for prostate cancer with Image Guided (IGRT), Intensity Modulated Radiotherapy (IMRT) IG-IMRT,
the best and most precise way of radiotherapy and brachytherapy existing today,
announced Professor Dr Benjamin Guix. This is the first centre employing
this technology of southern Europe, what convert it in the first option to have
the best radiotherapy abroad.
“This is the most precise and modern way for treating
cancer” stated Professor Benjamin
Guix, and is applied mainly prostate cancer, lung cancer, head and neck
cancer, brain tumors and liver metastases as well as liver cancer. JORNADA_IGRT_IMOR_2006_eng.htm
·
The IMOR
Foundation, Medical Institute for Radiotherapy and Oncology from Barcelona, Spain has begun the Image Guided Radiotherapy (IGRT), for
the first time in Spain, and southern Europe, announced its director Professor Benjamin Guix. This is the best way for
treating tumors nowadays, mainly for prostate cancer, lung cancer, head and
neck cancer, brain tumors, breast cancer and liver metastases or primary
tumors, among others. The IMOR Foundation, Medical Institute for Radiotherapy
and Oncology of Barcelona, Spain, is one
of the best places to have cancer treatment abroad. IGRT_IMOR_2005_ENG.htm
·
Combined treatment with 3D- conformal Radiotherapy/ IGRT IMRT + Brachytherapy either with I-125
permanent implant or HDR temporal implant, is associated with excellent 3- and 5- year disease-free
survival rates in patients with clinically localized prostate cancer and high PSA levels. Data has been
presented by Dr Benjamin Guix at the
ASTRO (American Society for Radiotherapy and Oncology) meeting. At the same
meeting, Dr Benjamin Guix and Dra Teresa Maria Lacorte, from The IMOR
Foundation, Medical Institute for Radiotherapy and Oncology of Barcelona,
Spain, presented the results obtained at
IMOR Foundation with combined treatment, with a 8-year cure rate >95% and
with wxcellent Quality of life. These studies confirm Combined treatment as the
best treatment for prostate cancer. The IMOR
Foundation, Medical Institute for Radiotherapy and Oncology of Barcelona,
Spain, offers the best option to
have cancer treatment abroad, with
the highest quality.PROSTATe_COMBINED_TREAT_2005.htm
·
Dr Benjamin
Guix, Director of the IMOR Foundation, Medical Institute for Radiotherapy
and Oncology of Barcelona, Spain, has presented in the World Brachytherapy
Congress the long-term results of prostate brachytherapy for low- intermediate-
and high-risk prostate cancer. Results are really spectacular, with extremely
high disease-free survival and excellent quality of life. This is the best treatment for prostate cancer.
·
Dr Benjamin
Guix, Director of the IMOR Foundation presents the European experience in
prostate brachytherapy during the World Congress of Brachytherapy, the best
meeting of radiotherapy and brachytherapy.
·
Gynaecological
Brachytherapy considered as the standard
treatment for the best treatment for
gynaecologycal cancer, informed Dr Jose Antonio Lejarcegui and Professor Dr
Benjamin Guix, Director of The IMOR Foundation, Medical Institute for Radiotherapy
and Oncology of Barcelona, Spain. IMOR Foundation, Medical Institute for Radiotherapy
and Oncology of Barcelona, Spain, has the
best team with the highest technology to have cancer treatment abroad GINE1-ct.htm
·
Prostate
Brachytherapy, increases local control at the same time that decreases side-effects
in prostate cancer, as shown by a multi-center study, in which the contribution
of Doctors from The IMOR Foundation,
Medical Institute for Radiotherapy and Oncology from Barcelona, Sapin, has been very
important, that has been presented by Professor Dr Benjamin Guix, Director of the IMOR
Foundation at the ASCO 2005 ANNUAL
MEETING (American Society for Clinical Oncology), held at Chicago (USA).
This treatment offers the best
disease-free survival and the best quality of life for prostate cancer.
·
Brachytherapy-only,
is
a highly effective treatment for breast recurrences. This data have been
confirmed by a trial conducted by scientifics from The IMOR Foundation, Medical Institute for Radiotherapy and Oncology from Barcelona, Spain, presented by Professor
Dr Benjamin Guix, at the GEC-ESTRO
European Meeting on Brachytherapy, held at Lubeck (Germany), considered the
best brachytherapy meeting. Brachytherapy is the most effective treatment for cancer.
·
Brachytherapy
offers more than 90 % local control in cancer. Professor Alain Gerbaulet,
former Head of the Brachytherapy Unit from Institute Gustav-Roussy, made this
assertion in the II International
Oncological Meeting, invited by Professor Dr Benjamin Guix Director of the IMOR
Foundation. Nowadays, brachytherapy offers the
best results for cancer treatment. The IMOR Foundation, Medical Institute for
Radiotherapy and Oncology of Barcelona, Spain, offers the highest technology
and the most experienced team for treating cancer abroad in southern
Europe.
·
The last 8th of april, IMOR Foundation, Medical Insitute for Radiotherapy and Oncology,
held the Ist International Conference
about Advances on Brachytherapy. World leaders in this effective and useful
form of cancer treatment discussed about the recent developments and
discoveries and the state of the art of this extraordinary technique. The
Conference was presided by the catalan minister of Health and Social Security
Mr. Xavier Pomés. By the IMOR Foundation, Medical Institute for Radiotherapy
and Oncology of Barcelona, Spain, presented their results Drs Antonio Arellano,
Ferran Guedea and Professor Dr Benjamin Guix and the physicist Jose Ignacio
Tello, about the best radiotherapy
treatment.
·
Brachytherapy
boost useful in early breast cancer. Stage I and II breast
tumors that are treated by a brachytherapy boost are doing better than those
patients without boost even if they have poor prognostic factors as positive
margins, extensive intraductal component or vascular invasion, according to a
consensus meeting held in Barcelona. Results confirm the IMOR Foundation
long-term experience, presented by Professor Dr Benjamin Guix and Jose Antonio
Lejarcegui. The results confirm the
boost as the best option of treatment for breast cancer. This data confirms
The IMOR Foundation, Medical Institute for Radiotherapy and Oncology of
Barcelona, Spain,long-term
experience for breast cancer treatment
abroad. Brachytherapy boost in early breast cancer.
·
Local relapses
after conservative treatment for breast cancer, can be safely managed without
mastectomy by means of brachytherapy-only, as a phase II study
presented by Professor Dr Benjamin Guix Director of the IMOR
Foundation, Medical Institute for Radiotherapy and Oncology of Barcelona,
Spain, at the ASCO meeting has demonstrated. The brachytherapy is the
best treatment for breast cancer recurrences. Trat_recidivas_mama_CAST.htm
·
Temporary PSA bounces has no significant prognostic
importance, as confirmed by a paper published in the International Journal of
Radiation Oncology Biology and Physics, Dr Benjamin Guix Melcior explained
recently. The study confirms brachytherapy,
alone or in combination with IGRT-IMRT in selected cases, as the best treatment for prostate cancer.
The IMOR Foundation, Medical Institute for Radiotherapy and Oncology of
Barcelona, Spain, has the longest and highest experience in prostate cancer treatment in souther
Europe, with more than 1,000 cases treated, and is the best option for cancer treatment abroad. PSA SPIKES_ANG.htm
·
Partial Breast
Irradiation (PBI) by Brachytherapy-only very effective treatment for early
stage breast cancer. Differents reports appeared in the Journal of
Clinical Oncology confirm that PBI is a very effective treatment for selected cases of low-risk
small-size breast cancer, professor Dr Benjamin Guix, Director of the IMOR
Foundation, Medical Institute for Radiotherapy and Oncology from Barcelona,
Spain,, reported recently. The IMOR Foundation, Medical Institute for Radiotherapy
and Oncology of Barcelona, Spain, has the world series with longer follow-up of
partial breast irradiation, with the
state of the art technology and best team. The IMOR Foundation, Medical Institute for Radiotherapy and Oncology of
Barcelona, Spain, is the best option to have breast cancer treatment abroad. BREAST_BRACHYTHERAPY_ONLY.htm
·
Contents about Professor
Dr Benjamin Guix Melcior, in the best selection, Director of The IMOR Foundation, Medical Institute for
Radiotherapy and Oncology of Barcelona, Spain,
·
:
La braquiterapia
como tratamiento exclusivo en pacientes con cáncer de mama de bajo
riesgo
La Braquiterapia como único tratamiento tras cirugía
conservadora en los casos precoces de cáncer de mama, está
demostrando ser tan efectiva como la radioterapia de toda la mama. Un reciente trabajo
aparecido en la revista Internacional Journal of Radiation Oncology Biology
Physics (IJROBP 2003 55:289-293), publicado por el conjunto de investigadores
de Estados Unidos que trabajan desde hace años en la irradiación
parcial de la mama, refiere que la braquiterapia exclusiva tras
tumorectomía es un tratamiento seguro, con pocos efectos secundarios y
pocas complicaciones y que ofrece unos resultados (al menos a corto plazo)
similares a los obtenidos con radioterapia a toda la mama. Las principales ventajas
de la técnica están relacionadas fundamentalmente con el
acortamiento de la duración total del tratamiento, que sería de 5
días en vez de las 5 semanas y media que normalmente dura. En un primer
momento, el tratamiento está limitado a las pacientes con tumores de
riesgo bajo, esto es tumores de hasta 2 cm de diámetro, sin ganglios
axilares positivos, menopáusicas y cuyos tumores presenten receptores
hormonales positivos.
En el mismo acto de la intervención en la cual se extirpa
el tumor mamario, se coloca en el interior de la cavidad el aplicador de
braquiterapia. Al cabo de 3 días se realiza un TAC para la
dosimetría y se inicia el tratamiento, que tiene una duración de
5 días y se realiza de forma totalmente ambulatoria. Una vez acabado el
tratamiento se retira el aplicador sin necesidad de anestesia,
iniciándose los controles periódicos habituales.
Los efectos secundarios que se observan en algunos casos se
reducen a un enrojecimiento de la piel situada sobre la cavidad tratada.
La Fundación IMOR, es el centro pionero en España y
Europa en estos tipos de tratamiento. Iniciados en 1990, hasta la fecha han
sido tratadas más de 100 pacientes, siendo los resultados obtenidos muy
favorables y sin complicaciones tardías relevantes. Los resultados han sido
presentados por el Profesor Benjamín Guix, Director de la
Fundación IMOR, Instituto Médico de Onco-Radioterapia, en
mútiples foros internacionales, especialmente el Congreso de ASTRO
(Sociedad Americana de Radioterapia) y de ASCO (Sociedad Americana de
Oncología Clínica). El Dr Benjamin Guix, ha destacado en todos
dichos foros la ausencia de complicaciones a largo plazo y el hecho de que 14
de cada 15 pacientes siguen conservado su mama en perfectas condiciones
más de 15 años después de la recaida. El Dr Benjamin Guix,
explica que la base de estos buenos resultados radica en una cuidadosa
selección de las pacientes tributarias del tratamiento y en una depurada
técnica. “Es realmente maravilloso”, declaró Benjamin
Guix “el hecho de que sigas viendo a las pacientes 15 años
después del tratamiento en perfectas condiciones y preservando su mama.
Esto anima mucho a las pacientes y, evidentemente a los médicos”,
concluyó el prof. Benjamin Guix.
Links de interés sobre el Dr. Benjamin Guix:
Pagina web de Fundación IMOR: www.imor.org
CV abreviado del Dr Benjamin Guix: www.sanestconsultores.com/uploads/Dr_Benjam_n_Guix_Cv.doc
Presentacion del Dr Benjamin Guix en la 13th Puerto Rico Breasr
cancer conference: www.acro.org/pdf/BCConference13-bro-w3.pdf
Página de noticias a cargo del Dr. Benjamin Guix www.imor.org/noticias/contenidos3_cast
Presentacion del Dr Benjamin Guix en la conferencia anual de ASCO www.asco.org/ASCO/Abstarcts+&+virtual+Meeting/Speaker?&spk=Guix%2C+Benjamin+%
Reseña de la presentacion de la braquiterapia transperineal
para el tratamiento del cancer de próstata efectuada por el Dr Benjamin
Guix, aparecida en Diario Medico:
http://212.80.128.9/oncologia/n140900bis.html
Otras presentaciones a cargo del Dr. Benjamin Guix
http://profesional.medicinatv.com/webcast/muestra.asp?idfg=0&idwc=1387
http://www.sanestconsultores.com/uploads/Dr_Benjam_n_Guix_CV.doc
Volver a la pagina de
noticias contenido3_cast.htm
Regresar a la pagina
de inicio ../index.htm
Consultar la web en
Català
http://www.imor.org/index_cat.htm
Tornar a la pagina
principal de noticies en Català contenido3_cat.htm
Consult the web in english http://www.imor.org/index_ang.htm
Consult news in english contenido3_ang.htm
Sobredosis de braquiterapial_archivos
Braquiterapia_prostata_15 a_CAST.htm
JORNADA_IGRT_IMOR_2006_eng.htm
MAMA_BRAQUITERAPIA_EXCLUSIVA_CAST.htm
MAMA_BRAQUITERAPIA_EXCLUSIVA_CAT.htm
PROSTATA_TRAT_COMBINADO_2005.htm
PROSTATe_COMBINED_TREAT_2005.htm
Sobredosis de braquiterapial.htm
PROSTATA_TRAT_COMB_2006\BLASKO_COMBINED-IJROBP
2006.pdf
Noticias en inglés: contenido3_ang.htm
Noticies en Català: contenido3_cat.htm
Volver a la página
principal ../index.htm
Contenido en castellano BENJAMIN GUIX_CAST.htm
Contenido en Catalá BENJAMIN GUIX_CAT.htm
Contens in English
Medicina tv: Doctor Benjamin Guix Melcior http://profesional.medicinatv.com/webcast/muestra.asp?idfg=0&idwc=1387
Medicina tv: Doctor Benjamin Guix Melcior http://profesional.medicinatv.com/webcast/mplayer.asp?id_wc=1387&id_fg=0
http://profesional.medicinatv.com/webcast/mplayer.asp?id_wc=1387&id_fg=1
http://profesional.medicinatv.com/webcast/mplayer.asp?id_wc=1387&id_fg=2
http://profesional.medicinatv.com/webcast/mplayer.asp?id_wc=1387&id_fg=3
http://profesional.medicinatv.com/webcast/mplayer.asp?id_wc=1387&id_fg=4
http://profesional.medicinatv.com/webcast/mplayer.asp?id_wc=1387&id_fg=5
http://profesional.medicinatv.com/webcast/mplayer.asp?id_wc=1387&id_fg=6
http://profesional.medicinatv.com/webcast/mplayer.asp?id_wc=1387&id_fg=7
Indicie capítulos libros
braqui: http://www.aero.es/UserFiles/File/actualidad/Grupos%20de%20trabajo/AutoresCapitulos_v2%20modificada.pdf
CV Profesor doctor Benjamin
Guix Melcior en Sanest consultores: http://www.sanestconsultores.com/uploads/Dr_Benjam_n_Guix_CV.doc
Vivir Mejor:
Braquiterapia de
próstata, el tratamiento ideal para el cancer de próstata: http://www.vivirmejor.es/es/oncologia-medica/noticia/actualidad/braquiterapia-de-prostata-el-tratamiento-ideal-para-el-cancer-de-prostata-03040.html
El porcentaje de recaida en un
cancer de próstata localizado tratado con braquiterapia es solo del 1 % http://www.vivirmejor.es/es/oncologia-medica/noticia/v/109/actualidad/el-porcentaje-de-recaida-en-un-cancer-de-prostata-localizado-tratado-con-braquiterapia-es-solo-del-1.html
Los tratamientos conservadores
en cancer de próstata tienen mas preponderancia, son cada día mas
usados http://www.vivirmejor.es/es/oncologia-medica/noticia/v/109/actualidad/los-tratamientos-conservadores-en-cancer-de-prostata-tienen-mas-preponderancia-02928.html
La brquiterapia preserva la
funcion eréctil en tumores prostaticos http://www.vivirmejor.es/es/oncologia-medica/noticia/v/109/actualidad/la-braquiterapia-preserva-la-funcion-erectil-en-tumores-prostaticos-02853.html
La braquiterapia elimina el
cancer de próstata sin provocar impotencia sexual http://www.vivirmejor.es/es/oncologia-medica/noticia/v/109/actualidad/la-braquiterapia-elimina-el-cancer-de-prostata-sin-provocar-impotencia-sexual-01766.html
La braquiterapia casi sin efectos
secundarios en el tratamiento del cancer de próstata: http://www.vivirmejor.es/es/oncologia-medica/noticia/v/109/actualidad/la-braquiterapia-casi-sin-efectos-secundarios-en-el-tratamiento-del-cancer-de-prostata-02734.html
La braquiterapia evita recaidas de
cancer de próstata en casi todos los casos http://www.vivirmejor.es/es/oncologia-medica/noticia/v/109/actualidad/la-braquiterapia-evita-recaidas-de-cancer-de-prostata-en-casi-todos-los-casos-02634.html
Braquiterapia y radioterapia guiada
por la imagen (IMRT-IGRT) combinadas muy efectivas en el tratamiento del cancer
de prostata http://www.vivirmejor.es/es/oncologia-medica/noticia/v/109/actualidad/02495.html
Destacan la braquiterapia como
mejor metodo contra el cancer de prostata http://www.vivirmejor.es/es/oncologia-medica/noticia/v/109/actualidad/destacan-la-braquiterapia-como-mejor-metodo-contra-el-cancer-de-prostata-02168.html
La braquiterapia permite aumentar
la supervivencia en el cancer de prostata http://www.vivirmejor.es/es/oncologia-medica/noticia/v/109/actualidad/la-braquiterapia-permite-aumentar-la-tasa-de-supervivencia-01913.html
El cancer de próstata puede
curarse http://www.vivirmejor.es/es/oncologia-medica/noticia/v/109/actualidad/el-cancer-de-prostata-puede-curarse-0903.html
La braquiterapia ya se aplica en
tumores de mama que no se han extendido http://www.vivirmejor.es/es/oncologia-medica/noticia/v/109/actualidad/la-braquiterapia-ya-se-aplica-en-tumores-de-mama-que-no-se-han-extendido-01663.html
Doctor Benjamín Guix Melcior at IMOR Foundation (Funndacion IMOR):
http://www.imor.org/noticias/BENJAMIN%20GUIX_CAST.htm
http://www.imor.org/noticias/contenido3_cast.htm
Patente aplicador oftalmico
doctor Benjamín Guix Melcior: http://www.invenia.es/inveniatags:guix_melcior_benjamin
Noticia Braquiterapia en
recidivas mama bajo riesgo: http://braquiterapia.biz/noticias/MAMA_BRAQUITERAPIA_EXCLUSIVA_CAST.htm
Abstract congreso ASCO 2001
Presentacion profesor doctor Benjamín Guix Melcior http://gucancers.asco.org/portal/site/ASCO/menuitem.34d60f5624ba07fd506fe310ee37a01d/?vgnextoid=76f8201eb61a7010VgnVCM100000ed730ad1RCRD&vmview=abst_detail_view&confID=10&abstractID=1888
Abstract congreso ASCO 2002
Presentacion profesor doctor Benjamín Guix Melcior http://gucancers.asco.org/ASCO/Abstracts+%26+Virtual+Meeting/Abstracts?&vmview=abst_detail_view&confID=16&abstractID=201
Abstract congreso ASCO 2003 Presentacion
profesor doctor Benjamín Guix Melcior http://gucancers.asco.org/ASCO/Abstracts+%26+Virtual+Meeting/Abstracts?&vmview=abst_detail_view&confID=23&abstractID=101894
Abstract congreso ASCO 2004
Presentacion profesor doctor Benjamín Guix Melcior http://gucancers.asco.org/ASCO/Abstracts+%26+Virtual+Meeting/Abstracts?&vmview=abst_detail_view&confID=26&abstractID=2862
Abstract congreso ASCO 2005_1
Presentacion profesor doctor Benjamín Guix Melcior http://gucancers.asco.org/ASCO/Abstracts+%26+Virtual+Meeting/Abstracts?&vmview=abst_detail_view&confID=37&abstractID=20089
Abstract congreso ASCO 2005_2
Presentacion profesor doctor Benjamín Guix Melcior http://gucancers.asco.org/ASCO/Abstracts+%26+Virtual+Meeting/Abstracts?&vmview=abst_detail_view&confID=34&abstractID=33781
Abstract congreso ASCO 2006_1
Presentacion profesor doctor Benjamín Guix Melcior http://gucancers.asco.org/ASCO/Abstracts+%26+Virtual+Meeting/Abstracts?&vmview=abst_detail_view&confID=42&abstractID=20241
Abstract congreso ASCO 2006_2
Presentacion profesor doctor Benjamín Guix Melcior http://gucancers.asco.org/ASCO/Abstracts+%26+Virtual+Meeting/Abstracts?&vmview=abst_detail_view&confID=40&abstractID=33820
Abstract congreso ASCO 2007_1
Presentacion profesor Benjamín Guix Melcior http://gucancers.asco.org/ASCO/Abstracts+%26+Virtual+Meeting/Abstracts?&vmview=abst_detail_view&confID=46&abstractID=20480
Abstract congreso ASCO 2007_2
Presentacion profesor Benjamín Guix Melcior http://gucancers.asco.org/ASCO/Abstracts+%26+Virtual+Meeting/Abstracts?&vmview=abst_detail_view&confID=47&abstractID=34072
Abstract congreso ASCO 2008
Presentacion profesor Benjamín Guix Melcior http://gucancers.asco.org/ASCO/Abstracts+%26+Virtual+Meeting/Abstracts?&vmview=abst_detail_view&confID=54&abstractID=20477
Participación en la
Puerto Rico Breast Cancer Conference http://www.acro.org/pdf/BCConference13-bro-w3.pdf
Cursos e-magister profesor
doctor Benjamín Guix http://www.emagister.com/benjamin-tps-949054.htm
Cursos e-magister profesor
doctor Benjamín Guix http://www.emagister.com/radiologia-diagnostica-terapeutica-nuclear-cursos-2447268.htm
Temario UIC profesor doctor
benjamín guix melcior http://www.unica.edu/progs/info_asig.uic?cod_asignatura=3157&anyo=2007&lg=1&huic=f0860f2b9c509b6b8f2a7593b999b671
Temario asignatura podologia UB
profesor doctor benjamín guix melcior http://www.ub.es/infermeria/podologia/programes/6es/Radiodiagn%F2stic%20i%20radioprotecci%F3%20podol%F2gica.doc
BOE tribunal profesor doctor
Benjamín Guix Melcior http://www.boe.es/boe/dias/2002/05/27/pdfs/A18868-18869.pdf
BOE tribunal profesor doctor
Benjamín Guix Melcior http://www.boe.es/boe/dias/2001/06/16/pdfs/A21457-21457.pdf
Prostate cancer treatment abroad by profesor Benjamín Guix
Melcior & Sanest IMOR Foundation http://www.sanestconsultores.com/Prostate_Cancer_treatment.html
Prologo por profesor doctor
Benjamin Guix Melcior Radiologia bucal http://books.google.com/books?id=6qU2dwvHNzMC&pg=PR5&lpg=PR5&dq=benjamin+guix&source=web&ots=btVod_L7Jj&sig=-vW_Iwq3ZGcRqXR-d19SBb6ydjM
Libro profesor doctor
Benjamín Guix Melcior Finestres http://books.google.com/books?id=_QoDug48TVkC&pg=PP6&lpg=PP6&dq=benjamin+guix&source=web&ots=bOuZKRPkfV&sig=gDnIq42_niaprwbKBiQlGBG0CtY
Radioterapia en Sociedad
Española de Medicina del dolor http://www.sedolor.es/noticia.php?id=394
·
IMOR Foundation web site www.imor.org,
·
Benjamin Guix MD PhD MBA home page,
Director of the IMOR Foundation web page
www.telefonica.net/web2/benjaminguix
www.telefonica.net/web2/bguix
www.telefonica.net/web2/b_guix
www.telefonica.net/web2/braquiterapia
www.telefonica.net/web2/brachytherapy
www.telefonica.net/web2/imrt www.telefonica.net/web2/cancerprostata
·